Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
Fig.4.b
Thélie A et al. (2015) |
Xla Wt + Flag-Mmu.prdm12
NF32 (in situ hybridization) |
|
||||
Fig.4.d
Thélie A et al. (2015) |
Xla Wt + Flag-Mmu.prdm12
NF32 (in situ hybridization) |
|
||||
Fig.4.e
Thélie A et al. (2015) |
Xla Wt + Flag-Mmu.prdm12
NF32 (in situ hybridization) |
|
||||
Fig.4.f
Thélie A et al. (2015) |
Xla Wt + Flag-Mmu.prdm12
NF32 (in situ hybridization) |
|
||||
Fig.7.f
Thélie A et al. (2015) |
Xla Wt + Flag-Mmu.prdm12
NF32 (in situ hybridization) |
|
||||
Fig.3.d
Thélie A et al. (2015) |
Xla Wt + prdm12 MO
NF28 (in situ hybridization) |
|
||||
Fig.3.f
Thélie A et al. (2015) |
Xla Wt + prdm12 MO
NF28 (in situ hybridization) |
|
||||
Fig.7.f
Thélie A et al. (2015) |
Xla Wt + prdm12 MO
NF32 (in situ hybridization) |
|
||||
Fig.5.c
Thélie A et al. (2015) |
Xla Wt + prdm12-EnR-Flag
NF32 (in situ hybridization) |
|
||||
Fig.5.c
Thélie A et al. (2015) |
Xla Wt + VP16-Flag-prdm12
NF32 (in situ hybridization) |
|